ReposiTrak (NYSE:TRAK) CEO Sells $21,875.00 in Stock

ReposiTrak Inc. (NYSE:TRAK) CEO Randall Fields sold 2,500 shares of ReposiTrak stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $8.75, for a total transaction of $21,875.00. Following the completion of the sale, the chief executive officer owned 97,500 shares in the company, valued at approximately $853,125. This trade represents a 2.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

ReposiTrak Stock Down 4.0%

TRAK opened at $8.60 on Friday. ReposiTrak Inc. has a twelve month low of $8.11 and a twelve month high of $23.72. The company has a 50-day moving average price of $10.46 and a 200 day moving average price of $13.46. The company has a market cap of $156.52 million, a PE ratio of 23.24 and a beta of 0.49.

ReposiTrak (NYSE:TRAK) last posted its quarterly earnings data on Tuesday, February 17th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.52% and a net margin of 30.62%.The company had revenue of $5.86 million for the quarter.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of ReposiTrak in a research note on Monday, December 29th. Wall Street Zen lowered ReposiTrak from a “buy” rating to a “hold” rating in a report on Saturday, January 17th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. XTX Topco Ltd acquired a new position in shares of ReposiTrak during the 4th quarter worth approximately $214,000. Occudo Quantitative Strategies LP acquired a new stake in shares of ReposiTrak in the fourth quarter valued at approximately $147,000. Price T Rowe Associates Inc. MD lifted its position in ReposiTrak by 23.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 28,094 shares of the company’s stock worth $348,000 after buying an additional 5,400 shares in the last quarter. Rice Hall James & Associates LLC boosted its stake in ReposiTrak by 6.4% during the fourth quarter. Rice Hall James & Associates LLC now owns 793,858 shares of the company’s stock worth $9,820,000 after buying an additional 47,914 shares during the last quarter. Finally, Squarepoint Ops LLC grew its holdings in ReposiTrak by 39.5% in the 4th quarter. Squarepoint Ops LLC now owns 99,830 shares of the company’s stock valued at $1,235,000 after buying an additional 28,282 shares in the last quarter. 27.35% of the stock is owned by hedge funds and other institutional investors.

ReposiTrak Company Profile

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.